Metabolic Syndrome and Fall Risk
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autonomic Neuropathy
- Metabolic Syndrome
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: parallel treatmentsMasking: Single (Outcomes Assessor)Masking Description: single blindPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 45 years and 75 years
- Gender
- Both males and females
Description
Active, not recruiting due to COVID-19 55 participants with evidence of the MetS and autonomic neuropathy will be assessed for fall risk with the Four Square Step Test (FSST), which is a measure of dynamic standing balance. Additional endpoints include the dynamic gait index. Measures of height, wei...
Active, not recruiting due to COVID-19 55 participants with evidence of the MetS and autonomic neuropathy will be assessed for fall risk with the Four Square Step Test (FSST), which is a measure of dynamic standing balance. Additional endpoints include the dynamic gait index. Measures of height, weight, and waist circumference will be taken and an oral glucose tolerance test as well as lipids and blood pressure will also be measured. Autonomic function will be measured using cardiac autonomic testing, quantitative sudomotor axon reflex test and tilt table testing. Participants will be randomized into either a standard care group that will receive fall risk education or a targeted balance exercise intervention group. Both groups will meet once a week. The intervention group will receive a 12 week balance program with personalized incremental increases in the amount and difficulty of each maneuver.
Tracking Information
- NCT #
- NCT02633891
- Collaborators
- University of Maryland, College Park
- Investigators
- Principal Investigator: Lindsay A Zilliox, MD Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD